Anne-Marie Koop

6 243 by the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation, Dutch Federation of University Medical Centers, the Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of Sciences (CVON-Phaedra 2012-08). PDCM was supported by a Dutch Heart Foundation grant (NHS2010B261) and a Foundation for Science and Technology of Portugal (FCT) grant (PTDC/BIM-MEC/4578/2014). CONFLICT OF INTEREST PDCM is one of the cofounders of Mirabilis Therapeutics.